Compare APLE & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | APLE | HTFL |
|---|---|---|
| Founded | 2007 | 2007 |
| Country | United States | United States |
| Employees | N/A | 843 |
| Industry | Real Estate Investment Trusts | |
| Sector | Real Estate | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.5B |
| IPO Year | 2007 | N/A |
| Metric | APLE | HTFL |
|---|---|---|
| Price | $14.50 | $29.53 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 5 |
| Target Price | $13.00 | ★ $38.20 |
| AVG Volume (30 Days) | ★ 2.8M | 1.0M |
| Earning Date | 05-04-2026 | 05-14-2026 |
| Dividend Yield | ★ 7.12% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.12 | N/A |
| Revenue | ★ $1,238,622,000.00 | N/A |
| Revenue This Year | $2.31 | $27.66 |
| Revenue Next Year | $2.35 | $23.55 |
| P/E Ratio | $120.75 | ★ N/A |
| Revenue Growth | ★ 18.98 | N/A |
| 52 Week Low | $10.85 | $20.13 |
| 52 Week High | $14.54 | $41.22 |
| Indicator | APLE | HTFL |
|---|---|---|
| Relative Strength Index (RSI) | 68.49 | 52.34 |
| Support Level | $11.50 | $28.60 |
| Resistance Level | N/A | $32.71 |
| Average True Range (ATR) | 0.31 | 1.92 |
| MACD | 0.02 | -0.25 |
| Stochastic Oscillator | 94.49 | 62.61 |
Apple Hospitality REIT Inc is a real estate investment trust that invests in income-producing real estate, majorly in the lodging sector, in the United States. It chiefly invests in upscale service hotels. All of the company's hotels operate under the Marriott or Hilton brands. Apple Hospitality has wholly-owned taxable REIT subsidiaries, which lease all of the company's hotels from wholly-owned qualified REIT subsidiaries. These hotels are managed under separate agreements with various hotel management companies that are unaffiliated with Apple Hospitality. The company derives its income from hotel revenue, its sole segment.
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.